RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+25.68%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.77B
AUM Growth
+$6.77B
(+5.8%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
45.13%
Holding
79
New
15
Increased
25
Reduced
7
Closed
10
Top Buys
| 1 |
Stryker
SYK
|
$115M |
| 2 |
Immatics
IMTX
|
$89.5M |
| 3 |
Dyne Therapeutics
DYN
|
$87.8M |
| 4 |
Merus
MRUS
|
$78.2M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$72.8M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$398M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$314M |
| 3 |
Celldex Therapeutics
CLDX
|
$137M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$112M |
| 5 |
Vericel Corp
VCEL
|
$83.6M |
Sector Composition
| 1 | Healthcare | 99.98% |
| 2 | Financials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Tourmaline Bio
TRML
$645M
| $17M | 0.25% |
741,656
+342,806
| +86% | +$7.85M |
|
52
Roivant Sciences
ROIV
$8.6B
| $15.3M | 0.23% |
1,454,273
| – | – |
|
53
Viridian Therapeutics
VRDN
$1.59B
| $10.6M | 0.16% |
605,816
| – | – |
|
54
Adicet Bio
ACET
$60.8M
| $9.72M | 0.14% |
4,134,631
| – | – |
|
55
Regenxbio
RGNX
$498M
| $7.37M | 0.11% |
+350,000
| New | +$7.37M |
|
|
SLRN
56
DELISTED
ACELYRIN
SLRN
| $6.6M | 0.1% |
978,310
| – | – |
|
57
Exact Sciences
EXAS
$9.33B
| $6.56M | 0.1% |
+95,000
| New | +$6.56M |
|
58
Allurion Technologies
ALUR
$16.5M
| $6.05M | 0.09% |
138,308
| – | – |
|
59
Immunic
IMUX
$79.4M
| $6.03M | 0.09% |
4,567,717
+232,462
| +5% | +$307K |
|
60
Milestone Pharmaceuticals
MIST
$151M
| $5.83M | 0.09% |
3,256,102
| – | – |
|
61
Glaukos
GKOS
$5.42B
| $5.54M | 0.08% |
+58,791
| New | +$5.54M |
|
62
Sagimet Biosciences
SGMT
$239M
| $5.42M | 0.08% |
+999,147
| New | +$5.42M |
|
63
Larimar Therapeutics
LRMR
$337M
| $4.93M | 0.07% |
+650,000
| New | +$4.93M |
|
64
SAB Biotherapeutics
SABS
$21.6M
| $4.17M | 0.06% |
917,827
-1
| -0% | -$5 |
|
65
Exagen
XGN
$213M
| $2.39M | 0.04% |
1,504,602
| – | – |
|
66
Beyond Air
XAIR
$12.1M
| $2.1M | 0.03% |
+60,241
| New | +$2.1M |
|
|
CUTR
67
DELISTED
Cutera, Inc.
CUTR
| $1.96M | 0.03% |
1,331,776
-485,809
| -27% | -$714K |
|
|
ARYD
68
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $1.44M | 0.02% |
127,970
| – | – |
|
69
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
$4.17M
| $105K | ﹤0.01% |
350,000
| – | – |
|
|
MRTX
70
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-6,768,514
| Closed | -$398M |
|
|
SIEN
71
DELISTED
Sientra, Inc.
SIEN
| – | – |
-81,016
| Closed | -$49.4K |
|
72
Tango Therapeutics
TNGX
$745M
| – | – |
-1,966,752
| Closed | -$19.5M |
|
|
SWTX
73
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-625,000
| Closed | -$22.8M |
|
74
Sight Sciences
SGHT
$199M
| – | – |
-164,806
| Closed | -$850K |
|
75
Guardant Health
GH
$8.11B
| – | – |
-492,977
| Closed | -$13.3M |
|